Trials & R&D · first seen yesterday, updated yesterday
Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks
Despite hitting a speed bump over the summer, automated cell therapy manufacturing specialist Cellares has continued to sign new partners at a steady pace, now inking a second agreement with an Asia-based organization in just over a week.
Summary from Fierce Pharma - Manufacturing.
Coverage 1 article · 1 outlet
-
Fierce Pharma - ManufacturingCellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks